S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BLRX BioLineRx Ltd

0.6859

0.0138 (2.05%)

03 May 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more BioLineRx Charts.

BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more BioLineRx Charts.

BioLineRx Ltd News

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Wednesday 17 April 2024 (2 weeks ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 30 December 2023 (4 months ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Saturday 30 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 21 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 12 December 2023 (5 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 20 November 2023 (5 months ago) • Edgar (US Regulatory)

Monday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and more
Monday 20 November 2023 (5 months ago) • IH Market News

BioLineRx a conclu un accord de licence exclusive pour le motixafortide en Asie, sous les conseils de MSQ Ventures
Wednesday 1 November 2023 (6 months ago) • PR Newswire (Canada)

More BioLineRx Ltd News Articles

Verizon Communications

Australian SE All Ordina...

Woodside Petroleum

Invesco QQQ Trust Series 1

JP Morgan Chase

Commonwealth Bank Of Aus...

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions